ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Osta Biotechnologies Inc. | OBI.H | Canada | — | 22 |
| Oxford Glycosciences Delisted | — | United Kingdom | — | 21 |
| BoYen Therapeutics,Inc. | 7891 | Taiwan | — | 20 |
| Elixiron Immunotherapeutics (Cayman) Limited | 7871 | Taiwan | — | 20 |
| LIBO PHARMA CORP. | 7888 | Taiwan | — | 20 |
| UWELL BIOPHARMA INC. | 7902 | Taiwan | — | 20 |
| Xenova Group Delisted | — | United Kingdom | — | 20 |
| 1608557 Ontario Inc. Delisted | OTROQ | Canada | — | 19 |
| Carmell Therapeutics Corporation Delisted | CTCX | United States of America | — | 19 |
| Technical Ventures RX Corp. Delisted | — | Canada | — | 18 |
| Curidium Medica PLC Delisted | — | United Kingdom | — | 17 |
| Proximagen Group PLC Delisted | — | United Kingdom | — | 16 |
| ACELYRIN, INC. Common Stock Delisted | SLRN | United States of America | — | 15 |
| Alizyme Delisted | — | United Kingdom | — | 14 |
| VBI Vaccines Inc Delisted | VBIV | Canada | — | 14 |
| Advectus Life Sciences Inc. Delisted | AVXSF | Canada | — | 13 |
| Curevac | CVAC | Netherlands | — | 13 |
| Eirx Therapeutics PLC Delisted | — | United Kingdom | — | 13 |
| Kiadis Pharma N.V Delisted | KDS | Netherlands | — | 13 |
| C4X Discovery Holdings PLC Delisted | C4XD | United Kingdom | — | 12 |
| MERRION PHARMACEUTICALS PLC Delisted | — | Ireland | — | 12 |
| TLC BioSciences Corp. | 7924 | Taiwan | — | 11 |
| Tripartite Therapeutics Inc. | 7920 | Taiwan | — | 11 |
| ZYNAXIS INC Delisted | — | United States of America | — | 11 |
| Henderson Morley Delisted | — | United Kingdom | — | 10 |
| Ingenia Therapeutics (인제니아테라퓨틱스) | 950260 | South Korea | — | 10 |
| Provalis Delisted | — | United Kingdom | — | 9 |
| Fusion Pharmaceuticals Inc Delisted | FUSN | Canada | — | 8 |
| Lipid Sciences Inc Delisted | LIPD | United States of America | — | 8 |
| Oncternal Therapeutics Inc Delisted | ONCT | United States of America | — | 8 |
| Ocera Therapeutics Inc Delisted | OCRX | United States of America | — | 7 |
| Windtree Therapeutics Inc | WINT | United States of America | — | 7 |
| Applied Genetic Delisted | AGTC | United States of America | — | 6 |
| Bioxytran, Inc. | — | United States of America | — | 6 |
| BiVictriX Therapeutics PLC Delisted | BVX | United Kingdom | — | 6 |
| Harvard Apparatus Regenerative Technology, Inc. (formerly Biostage, Inc.) | — | United States of America | — | 6 |
| Liminal BioSciences Inc Delisted | LMNL | Canada | — | 6 |
| Sirtris Pharmaceuticals Inc Delisted | SIRT | United States of America | — | 6 |
| Ambrx Biopharma Inc. American Depositary Shares Delisted | AMAM | United States of America | — | 5 |
| ZyVersa Therapeutics Inc. | ZVSA | United States of America | — | 5 |
| CARGO Therapeutics, Inc. Common Stock Delisted | CRGX | United States of America | — | 4 |
| Cessatech A/S | CESSA | Denmark | — | 4 |
| ChemoCentryx Inc Delisted | CCXI_old | United States of America | — | 4 |
| ConjuChem Biotechnologies Inc. Delisted | CJHMF | Canada | — | 4 |
| Medivation Inc Delisted | MDVN | United States of America | — | 4 |
| NEURODERM LTD Delisted | — | Israel | — | 4 |
| Neuropharm Group PLC Delisted | — | United Kingdom | — | 4 |
| Coley Pharmaceutical Group Inc Delisted | COLY | United States of America | — | 3 |
| Targanta Therapeutics Corp Delisted | TARG | United States of America | — | 3 |
| Turnstone Biologics Corp. Common Stock Delisted | TSBX | United States of America | — | 3 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.